Erratum: Inhibition of the processing of miR-25 by HIPK2-Phosphorylated-MeCP2 induces NOX4 in early diabetic nephropathy (Scientific Reports (2016) 6(38789) DOI: 10.1038/srep38789);Inhibition of the processing of miR-25 by HIPK2-Phosphorylated-MeCP2 induces NOX4 in early diabetic nephropathy

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Oh, Hyung Jung ^a,b   Kato, Mitsuo ^a   Deshpande, Supriya ^a   Zhang, Erli ^a,c   Sadhan, Das ^a   Lanting, Linda ^a   Wang, Mei ^a   Natarajan, Rama ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b Ewha Womans University   (South Korea)

^c TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; GLUCOSE; HIPK2 PROTEIN, MOUSE; MECP2 PROTEIN, MOUSE; MESSENGER RNA; METHYL CPG BINDING PROTEIN 2; MICRORNA; MIRN25 MICRORNA, MOUSE; NOX4 PROTEIN, MOUSE; PROTEIN; PROTEIN SERINE THREONINE KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SIAH1A PROTEIN, MOUSE; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DIABETIC NEPHROPATHY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENETICS; MESANGIUM; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; RNA INTERFERENCE;

ANIMALS; CARRIER PROTEINS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; GENE EXPRESSION REGULATION; GLOMERULAR MESANGIUM; GLUCOSE; METHYL-CPG-BINDING PROTEIN 2; MICE, INBRED C57BL; MICRORNAS; NADPH OXIDASE 4; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFORMING GROWTH FACTOR BETA;

EID: 85006059507     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep40832     Document Type: Erratum

References (63)

1. Jones, C. A. et al. Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? Kidney Int 67, 1684-1691, doi: 10. 1111/j. 1523-1755. 2005. 00265. x (2005).
2. Sarnak, M. J. et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108, 2154-2169 (2003).
3. Badal, S. S., Danesh, F. R. New insights into molecular mechanisms of diabetic kidney disease. American journal of kidney diseases : the official journal of the National Kidney Foundation 63, S63-83, doi: 10. 1053/j. ajkd. 2013. 10. 047 (2014).
4. Reidy, K., Kang, H. M., Hostetter, T., Susztak, K. Molecular mechanisms of diabetic kidney disease. The Journal of clinical investigation 124, 2333-2340, doi: 10. 1172/JCI72271 (2014).
5. Kanwar, Y. S., Sun, L., Xie, P., Liu, F. Y., Chen, S. A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annual review of pathology 6, 395-423, doi: 10. 1146/annurev. pathol. 4. 110807. 092150 (2011).
6. Brosius, F. C., Khoury, C. C., Buller, C. L., Chen, S. Abnormalities in signaling pathways in diabetic nephropathy. Expert review of endocrinology & metabolism 5, 51-64 (2010).
7. Ha, M., Kim, V. N. Regulation of microRNA biogenesis. Nature reviews. Molecular cell biology 15, 509-524, doi: 10. 1038/nrm3838 (2014).
8. Inui, M., Martello, G., Piccolo, S. MicroRNA control of signal transduction. Nature reviews 11, 252-263 (2010).
9. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233 (2009).
10. Liang, M. et al. MicroRNA: a new frontier in kidney and blood pressure research. American Journal of Physiology-Renal Physiology 297, F553-F558, doi: 10. 1152/ajprenal. 00045. 2009 (2009).
11. Denby, L., Baker, A. H. Targeting non-coding RNA for the therapy of renal disease. Current Opinion in Pharmacology 27, 70-77, doi: http://dx. doi. org/10. 1016/j. coph. 2016. 02. 001 (2016).
12. Kato, M., Natarajan, R. MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets. Annals of the New York Academy of Sciences 1353, 72-88, doi: 10. 1111/nyas. 12758 (2015).
13. Trionfini, P., Benigni, A., Remuzzi, G. MicroRNAs in kidney physiology and disease. Nat Rev Nephrol 11, 23-33, doi: 10. 1038/nrneph. 2014. 202 (2015).
14. Chung, A. C.-K., Lan, H. Y. MicroRNAs in renal fibrosis. Frontiers in Physiology 6, doi: 10. 3389/fphys. 2015. 00050 (2015).
15. Kato, M., Natarajan, R. Diabetic nephropathy-emerging epigenetic mechanisms. Nat Rev Nephrol 10, 517-530, doi: 10. 1038/nrneph. 2014. 116 (2014).
16. Gomez, I. G., Nakagawa, N., Duffield, J. S. MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis. American Journal of Physiology-Renal Physiology 310, F931-F944, doi: 10. 1152/ajprenal. 00523. 2015 (2016).
17. Simpson, K., Wonnacott, A., Fraser, D. J., Bowen, T. MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy. Current Diabetes Reports 16, 1-7, doi: 10. 1007/s11892-016-0724-8 (2016).
18. Kato, M. et al. TGF-beta induces acetylation of chromatin and of Ets-1 to alleviate repression of miR-192 in diabetic nephropathy. Sci Signal 6, ra43, doi: 10. 1126/scisignal. 2003389 (2013).
19. Chung, A. C., Huang, X. R., Meng, X., Lan, H. Y. miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J Am Soc Nephrol 21, 1317-1325, doi: ASN. 2010020134 [pii]10. 1681/ASN. 2010020134 (2010).
20. Kato, M. et al. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 11, 881-889, doi: 10. 1038/ncb1897 (2009).
21. Hajarnis, S. S. et al. Transcription Factor Hepatocyte Nuclear Factor-1? (HNF-1? ) Regulates MicroRNA-200 Expression through a Long Noncoding RNA. Journal of Biological Chemistry 290, 24793-24805, doi: 10. 1074/jbc. M115. 670646 (2015).
22. Kato, M. et al. An endoplasmic reticulum stress-regulated lncRNA hosting a microRNA megacluster induces early features of diabetic nephropathy. Nature communications 7, 12864, doi: 10. 1038/ncomms12864 http://www. nature. com/articles/ncomms12864#supplementary-information (2016).
23. Lewis, J. D. et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69, 905-914 (1992).
24. Nan, X., Meehan, R. R., Bird, A. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res 21, 4886-4892 (1993).
25. Nan, X. et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386-389, doi: 10. 1038/30764 (1998).
26. Guy, J., Cheval, H., Selfridge, J., Bird, A. The role of MeCP2 in the brain. Annu Rev Cell Dev Biol 27, 631-652, doi: 10. 1146/annurev-cellbio-092910-154121 (2011).
27. Cheng, T. L. et al. MeCP2 suppresses nuclear microRNA processing and dendritic growth by regulating the DGCR8/Drosha complex. Dev Cell 28, 547-560, doi: 10. 1016/j. devcel. 2014. 01. 032 (2014).
28. Woo, J. S., Kim, V. N. MeCP2 caught moonlighting as a suppressor of MicroRNA processing. Dev Cell 28, 477-478, doi: 10. 1016/j. devcel. 2014. 02. 015 (2014).
29. Denli, A. M., Tops, B. B., Plasterk, R. H., Ketting, R. F., Hannon, G. J. Processing of primary microRNAs by the Microprocessor complex. Nature 432, 231-235, doi: 10. 1038/nature03049 (2004).
30. Gregory, R. I. et al. The Microprocessor complex mediates the genesis of microRNAs. Nature 432, 235-240, doi: 10. 1038/nature03120 (2004).
31. Han, J. et al. The Drosha-DGCR8 complex in primary microRNA processing. Genes & development 18, 3016-3027, doi: 10. 1101/gad. 1262504 (2004).
32. Lee, Y. et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415-419, doi: 10. 1038/nature01957 (2003).
33. Bracaglia, G. et al. Methyl-CpG-binding protein 2 is phosphorylated by homeodomain-interacting protein kinase 2 and contributes to apoptosis. EMBO reports 10, 1327-1333, doi: 10. 1038/embor. 2009. 217 (2009).
34. Jin, Y. et al. A systems approach identifies HIPK2 as a key regulator of kidney fibrosis. Nature medicine 18, 580-588, doi: 10. 1038/nm. 2685 (2012).
35. Park, J. T. et al. Repression of let-7 by transforming growth factor-beta1-induced Lin28 upregulates collagen expression in glomerular mesangial cells under diabetic conditions. American journal of physiology. Renal physiology 307, F1390-1403, doi: 10. 1152/ajprenal. 00458. 2014 (2014).
36. Zhang, Z. et al. MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. FEBS Lett 583, 2009-2014, doi: S0014-5793(09)00385-8 [pii]10. 1016/j. febslet. 2009. 05. 021 (2009).
37. Fu, Y. et al. Regulation of NADPH oxidase activity is associated with miRNA-25-mediated NOX4 expression in experimental diabetic nephropathy. Am J Nephrol 32, 581-589, doi: 000322105 [pii] 10. 1159/000322105 (2010).
38. Wang, B. et al. Suppression of microRNA-29 Expression by TGF-beta1 Promotes Collagen Expression and Renal Fibrosis. J Am Soc Nephrol 23, 252-265, doi: ASN. 2011010055 [pii] 10. 1681/ASN. 2011010055 (2012).
39. Chen, H. Y. et al. MicroRNA-29b inhibits diabetic nephropathy in db/db mice. Mol Ther 22, 842-853, doi: 10. 1038/mt. 2013. 235 (2014).
40. Du, B. et al. High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells. FEBS Lett 584, 811-816, doi: 10. 1016/j. febslet. 2009. 12. 053 (2010).
41. Zhang, Z. et al. MicroRNA-451 regulates p38 MAPK signaling by targeting of Ywhaz and suppresses the mesangial hypertrophy in early diabetic nephropathy. FEBS Letters 586, 20-26, doi: http://dx. doi. org/10. 1016/j. febslet. 2011. 07. 042 (2012).
42. Brennan, E. P. et al. Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFbetaR1. J Am Soc Nephrol 24, 627-637, doi: 10. 1681/ASN. 2012060550 (2013).
43. Wang, B. et al. Transforming growth factor-beta1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b. Kidney international 85, 352-361, doi: 10. 1038/ki. 2013. 372 (2014).
44. Castro, N. E., Kato, M., Park, J. T., Natarajan, R. Transforming growth factor beta1 (TGF-beta1) enhances expression of profibrotic genes through a novel signaling cascade and microRNAs in renal mesangial cells. J Biol Chem 289, 29001-29013, doi: 10. 1074/jbc. M114. 600783 (2014).
45. Long, J., Wang, Y., Wang, W., Chang, B. H., Danesh, F. R. Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J Biol Chem 285, 23457-23465 (2010).
46. Gorin, Y., Block, K. Nox4 and diabetic nephropathy: with a friend like this, who needs enemies? Free radical biology & medicine 61, 130-142, doi: 10. 1016/j. freeradbiomed. 2013. 03. 014 (2013).
47. Sedeek, M. et al. Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy. American journal of physiology. Renal physiology 299, F1348-1358, doi: 10. 1152/ajprenal. 00028. 2010 (2010).
48. You, Y.-H., Quach, T., Saito, R., Pham, J., Sharma, K. Metabolomics Reveals a Key Role for Fumarate in Mediating the Effects of NADPH Oxidase 4 in Diabetic Kidney Disease. Journal of the American Society of Nephrology 27, 466-481, doi: 10. 1681/asn. 2015030302 (2016).
49. Jha, J. C. et al. Genetic Targeting or Pharmacologic Inhibition of NADPH Oxidase Nox4 Provides Renoprotection in Long-Term Diabetic Nephropathy. Journal of the American Society of Nephrology 25, 1237-1254, doi: 10. 1681/asn. 2013070810 (2014).
50. Jha, J. C. et al. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy. Diabetologia 59, 379-389, doi: 10. 1007/s00125-015-3796-0 (2016).
51. Setyowati Karolina, D., Sepramaniam, S., Tan, H. Z., Armugam, A., Jeyaseelan, K. miR-25 and miR-92a regulate insulin I biosynthesis in rats. RNA biology 10, 1365-1378, doi: 10. 4161/rna. 25557 (2013).
52. Kan, T. et al. The miR-106b-25 Polycistron, Activated by Genomic Amplification, Functions as an Oncogene by Suppressing p21 and Bim. Gastroenterology 136, 1689-1700, doi: http://dx. doi. org/10. 1053/j. gastro. 2009. 02. 002 (2009).
53. Wahlquist, C. et al. Inhibition of miR-25 improves cardiac contractility in the failing heart. Nature 508, 531-535, doi: 10. 1038/nature13073 (2014).
54. Petrocca, F., Vecchione, A., Croce, C. M. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer research 68, 8191-8194, doi: 10. 1158/0008-5472. CAN-08-1768 (2008).
55. Kato, M. et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA 104, 3432-3437, doi: 10. 1073/pnas. 0611192104 (2007).
56. Dey, N. et al. MicroRNA-21 Orchestrates High Glucose-induced Signals to TOR Complex 1, Resulting in Renal Cell Pathology in Diabetes. J Biol Chem 286, 25586-25603, doi: M110. 208066 [pii] 10. 1074/jbc. M110. 208066 (2011).
57. Kato, M. et al. A microRNA circuit mediates transforming growth factor-beta1 autoregulation in renal glomerular mesangial cells. Kidney Int 80, 358-368, doi: 10. 1038/ki. 2011. 43 (2011).
58. Park, J. T. et al. FOG2 protein down-regulation by transforming growth factor-beta1-induced microRNA-200b/c leads to Akt kinase activation and glomerular mesangial hypertrophy related to diabetic nephropathy. J Biol Chem 288, 22469-22480, doi: 10. 1074/jbc. M113. 453043 (2013).
59. Winter, M. et al. Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR. Nature cell biology 10, 812-824, doi: 10. 1038/ncb1743 (2008).
60. Calzado, M. A., De La Vega, L., Munoz, E., Schmitz, M. L. From top to bottom: the two faces of HIPK2 for regulation of the hypoxic response. Cell cycle (Georgetown, Tex. ) 8, 1659-1664 (2009).
61. Amir, R. E. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature genetics 23, 185-188, doi: 10. 1038/13810 (1999).
62. Chahrour, M., Zoghbi, H. Y. The story of Rett syndrome: from clinic to neurobiology. Neuron 56, 422-437, doi: 10. 1016/j. neuron. 2007. 10. 001 (2007).
63. Bellini, E. et al. MeCP2 post-translational modifications: a mechanism to control its involvement in synaptic plasticity and homeostasis? Frontiers in cellular neuroscience 8, 236, doi: 10. 3389/fncel. 2014. 00236 (2014).